Patents by Inventor David S. Goldfarb

David S. Goldfarb has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Citrate containing beverage
    Patent number: 10258645
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Grant
    Filed: February 15, 2018
    Date of Patent: April 16, 2019
    Assignees: New York University, General Hospital Corporation, The Regents of the University of California
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Citrate Containing Beverage
    Publication number: 20180169144
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Application
    Filed: February 15, 2018
    Publication date: June 21, 2018
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Citrate containing beverage
    Patent number: 9895396
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Grant
    Filed: August 21, 2017
    Date of Patent: February 20, 2018
    Assignees: New York University, General Hospital Corporation, The Regents of the University of California
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Citrate Containing Beverage
    Publication number: 20170340664
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Application
    Filed: August 21, 2017
    Publication date: November 30, 2017
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Citrate containing beverage
    Patent number: 9737564
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Grant
    Filed: March 7, 2016
    Date of Patent: August 22, 2017
    Assignees: New York University, General Hospital Corporation, The Regents of the University of California
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Citrate Containing Beverage
    Publication number: 20160184349
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Application
    Filed: March 7, 2016
    Publication date: June 30, 2016
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Citrate containing beverage
    Patent number: 9278112
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Grant
    Filed: March 14, 2014
    Date of Patent: March 8, 2016
    Assignees: New York University, General Hospital Corporation, The Regents of the University of California
    Inventors: David S. Goldfarb, Brian Eisner, John Asplin, Marshall L. Stoller
  • Modulation of Branched Amino Acid Concentrations to Treat Metabolic Diseases
    Publication number: 20150238441
    Abstract: The plasma concentration of at least one branched chain amino acid in a mammal in need of such reduction is reduced by administering an agent that increases the plasma concentration of large neutral amino acids. The invention also includes related compositions and methods. These methods and compositions can be used to treat insulin resistance, type 2 diabetes and metabolic syndrome.
    Type: Application
    Filed: October 7, 2013
    Publication date: August 27, 2015
    Applicant: University of Rochester
    Inventor: David S. Goldfarb
  • Compounds and methods for altering lifespan of eukaryotic organisms
    Patent number: 8846747
    Abstract: Provided are compounds which generally have a triketone structure. Examples of the compounds include derivatives of 1,3-cyclohexanedione, such as: 1,3-cyclohexanedione, 2-propanoyl-5-cyclohexyl-; 1,3-cyclohexanedione, 2-propanoyl-5-[4-fluorophenyl]-; 1,3-cyclohexanedione, 2-acetyl-5-[thien-2-yl]-; 1,3-cyclohexanedione, 2-acetyl-5-butyl-; and 1,3-cyclohexanedione, 2-propanoyl-5-[bicyclo[2.2.1]hept-2-en-5-yl]-. The compounds can be used to alter the lifespan of eukaryotic organisms and treat inflammation.
    Type: Grant
    Filed: November 17, 2010
    Date of Patent: September 30, 2014
    Assignees: University of Rochester, Southern Research Institute
    Inventors: David S. Goldfarb, Joseph A. Maddry, Lynn Rasmussen, Ellie Lucille White, Krister Wennerberg
  • CITRATE CONTAINING BEVERAGE
    Publication number: 20140271929
    Abstract: Provided are beverage compositions comprising a urine citrate increasing component and a urine oxalate reducing component. The beverage compositions may be provided in a ready-to-drink form or may be provided in a concentrate form. Also provided are kits comprising the beverage compositions and methods for treating various conditions using the beverage compositions.
    Type: Application
    Filed: March 14, 2014
    Publication date: September 18, 2014
    Inventors: David S. GOLDFARB, Brian EISNER, John ASPLIN, Marshall L. STOLLER
  • Compounds and Methods for Altering Lifespan of Eukaryotic Organisms
    Publication number: 20130096175
    Abstract: Provided are compounds which generally have a triketone structure. Examples of the compounds include derivatives of 1,3-cyclohexanedione, such as: 1,3-cyclohexanedione, 2-propanoyl-5-cyclohexyl-; 1,3-cyclohexanedione, 2-propanoyl-5-[4-fluorophenyl]-; 1,3-cyclohexanedione, 2-acetyl-5-[thien-2-yl]-; 1,3-cyclohexanedione, 2-acetyl-5-butyl-; and 1,3-cyclohexanedione, 2-propanoyl-5-[bicyclo[2.2.1]hept-2-en-5-yl]-. The compounds can be used to alter the lifespan of eukaryotic organisms and treat inflammation.
    Type: Application
    Filed: November 17, 2010
    Publication date: April 18, 2013
    Applicants: SOUTHERN RESEARCH INSTITUTE, UNIVERSITY OF ROCHESTER
    Inventors: David S. Goldfarb, Joseph A. Maddry, Lynn Rasmussen, Ellie Lucile White, Krister Wennerberg
  • Materials and methods for identifying genes and/or agents that alter replicative lifespan
    Patent number: 7618774
    Abstract: Recombinant materials, including DNA constructs, expression vectors, and host cells, and methods of identifying an environmental stimulus or a gene that alters the lifespan of an organism are identified. The recombinant DNA constructs include first and second chimeric genes that both encode substantially the same protein that is required for yeast replication, the first chimeric gene containing a promoter responsive to growth medium conditions and the second chimeric gene containing a promoter operable in mother cells but not daughter cells.
    Type: Grant
    Filed: March 1, 2004
    Date of Patent: November 17, 2009
    Assignee: University of Rochester
    Inventors: David S. Goldfarb, Michael Breitenbach
  • Materials and methods for identifying genes and/or agents that alter replicative lifespan
    Publication number: 20040265861
    Abstract: Recombinant materials, including DNA constructs, expression vectors, and host cells, and methods of identifying an environmental stimulus or a gene that alters the lifespan of an organism are identified. The recombinant DNA constructs include first and second chimeric genes that both encode substantially the same protein that is required for yeast replication, the first chimeric gene containing a promoter responsive to growth medium conditions and the second chimeric gene containing a promoter operable in mother cells but not daughter cells.
    Type: Application
    Filed: March 1, 2004
    Publication date: December 30, 2004
    Inventor: David S. Goldfarb